NCT00004175View on ClinicalTrials.gov

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1998

Primary Completion Date

September 30, 2004

Study Completion Date

June 30, 2005

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

doxorubicin hydrochloride

PROCEDURE

conventional surgery

Trial Locations (4)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

60603

Monroe Medical Associates, Chicago

94305-5408

Stanford University Medical Center, Stanford

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004175 - Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer | Biotech Hunter | Biotech Hunter